110 likes | 272 Vues
Collaborative Clinical Medicines Procurement. Procurement & Distribution Interest Group Autumn Symposium: 11 th November 2010 Dr Anthony Grosso Formulary & Medicines Management Pharmacist anthony.grosso@uclh.nhs.uk. Outline. Getting value for money: Outline. The past… The present…
E N D
Collaborative Clinical Medicines Procurement Procurement & Distribution Interest Group Autumn Symposium: 11th November 2010 Dr Anthony Grosso Formulary & Medicines Management Pharmacist anthony.grosso@uclh.nhs.uk
Getting value for money: Outline The past… The present… The future… Key messages
Proactive • Progressive • Savings ++ • Particularly effective for generic medicines The past: NHS Procurement
The past…NHS Clinical Passive & reactive initially Through collaboration: increased activity Statin project: key milestone
Medicine savings pathway: example Opportunity identified by procurement: PREDICTED price drop Opportunity assessed by clinical Jointly scoped estimated savings per scenario Stakeholder consultation Modifications Barriers identified Clinical evaluation Implementation Marketing & counter-marketing strategy employed Tracking & continual management
The present… - Active collaboration between procurement & clinical Opportunities identified by procurement – feasibility-tested and implementation led by clinical - Opportunities identified by clinical - forensic examination of individual drug use and discrete therapeutic pathways
Targets & Implementation Allows for generation of multiple targets & savings ++ Rank by level of saving vs. degree of effort Austerity – aids implementation! Proven track record e.g. Statins, ARBs, anti-TNFs, Growth Hormones, 5-ASAs, GCSFs, 5-HT3s etc…
The Future Increased clinical input into procurement groups Further adaptation required 2013 + (White paper, PPRS, VBP,NICE/NPC)
Key messages: NHS Clinical + procurement specialists: collaborate more closely to generate greater opportunities for saving money Innovate: look beyond price differences e.g. homecare savings Designate more time & resource to implementation activities Share ideas among colleagues
Key messages: Pharma Threats & opportunities Must adapt accordingly Collaborate with clinical-procurement groups Develop innovative ideas that are mutually beneficial Motivate decision-makers and influencers WITHIN the NHS to actively market your product for you!